Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy

Table 3

Potential Therapeutic Strategies and agent examples for TNBC.

Potential therapeutic strategies	Agent examples
Src inhibition	Dasatinib; Saracatanib
PARP inhibition	Olaparib; ABT-888
Androgen receptor inhibition	Bicalutamide
Targeting epigenetics	Decitabine; LBH589
EGFR pathway inhibition	Cetuximab
PI3K pathway inhibition	NVP-BEZ235; Everolimus